Myelomeningocele (MMC) is one of the most devastating, nonlethal congenital anomalies worldwide. The live birth prevalence of MMC changed dramatically in the 1980s with the introduction of maternal serum screening and the widespread use of prenatal ultrasound imaging. The high-resolution ultrasound affordable today with state-of-the-art equipment allows us to make a very accurate diagnosis of MMC, including details related to the entire fetal central nervous system. Ultrasound can accurately localize the site of the osseous and soft tissue defects. Congenital spinal defects can be characterized definitively as open or closed, which are treated very differently with in utero repair, which is done in some cases, compared to only conservative follow-up with postnatal therapy for occult defects. Additional findings of kyphosis, scoliosis and anomalous vertebrate and associated conditions such as cervical syrinx can be identified. The state of the intracranial structures, including the presence or absence of ventriculomegaly and hindbrain herniation, as well as unexpected complications such as intracranial hemorrhage can be diagnosed. The severity of neurological compromise in some fetuses can be estimated by detailed examination of the lower extremities. As well as searching for talipes, we also now routinely characterize flexion and extension motions at the hip, knee and ankle joints. The information provided by ultrasound plays a crucial role, now more than ever, in patient counseling and pregnancy management. This article emphasizes how we utilize ultrasound in the evaluation of patients with suspected MMC at the Center for Fetal Diagnosis and Treatment at the Children's Hospital of Philadelphia.

Keywords:
Fetal ultrasound, Spina bifida, Myelomeningocele, Ventriculomegaly, Hindbrain herniation, Syrinx, Kyphosis, Scoliosis
1.
Budorick NE, Pretorius DH, Grafe MR, Lou KV: Ossification of the fetal spine. Radiology 1991;181:561-565.
2.
Braithwaite JM, Armstrong MA, Economides DL: Assessment of fetal anatomy at 12-13 weeks of gestation by transabdominal and transvaginal sonography. BJ Obstet Gynaecol 1996;103:82-85.
3.
Zalel Y, Lehavi O, Aizenstein O, Achiron R: Development of the fetal spinal cord: time of ascendance of the normal conus medullaris as detected by sonography. J Ultrasound Med 2006;25:1397-1401.
4.
Aaronson OS, Hernanz-Schulman M, Bruner JP, Reed GW, Tulipan NB: Myelomeningocele: prenatal evaluation - comparison between transabdominal US and MR imaging. Radiology 2003;227:839-843.
5.
Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL: A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011;364:993-1004.
6.
Gregerson DM: Clinical consequences of spina bifida occulta. J Manipulative Physiol Ther 1997;20:546-550.
7.
Hertzler DA 2nd, DePowell JJ, Steveson CB, Mangano FT: Tethered cord syndrome: a review of the literature from embryology to adult presentation. Neurosurg Focus 2010;29:E1.
8.
Has R, Yuksel A, Buyukkurt S, Kalelioglu I, Tatli B: Prenatal diagnosis of diastematomyelia: presentation of eight cases and review of the literature. Ultrasound Obstet Gynecol 2007;30:845-849.
9.
Sarris CE, Tomei KL, Carmel PW, Gandhi CD: Lipomyelomeningocele: pathology, treatment, and outcomes. Neurosurg Focus 2012;33:E3.
10.
Kim SY, McGahan JP, Boggan JE, McGrew W: Prenatal diagnosis of lipomyelomeningocele. J Ultrasound Med 2000;19:801-805.
11.
Gupta DK, Mahapatra AK: Terminal myelocystoceles: a series of 17 cases. J Neurosurg 2005;103(suppl 4):344-352.
12.
Midrio P, Silberstein HJ, Bilaniuk LT, Adzick NS, Sutton LN: Prenatal diagnosis of terminal myelocystocele in the fetal surgery era: case report. Neurosurgery 2002;50:1152-1155.
13.
Meyer SH, Morris GF, Pretorius DH, James HE: Terminal myelocystocele: important differential diagnosis in the prenatal assessment of spina bifida. J Ultrasound Med 1998;17:193-197.
14.
Rossi A, Piatelli G, Gandolfo C, Pavanello M, Hoffmann C, Van Goethem JW, Cama A, Tortori-Donati P: Spectrum of nonterminal myelocystoceles. Neurosurgery 2006;58:509-515.
15.
Blaas HG, Eik-Nes SH, Isaksen CV: The detection of spina bifida before 10 gestational weeks using two-and three-dimensional ultrasound. Ultrasound Obstet Gynecol 2000;16:25-29.
16.
Sauerbrei EE: The fetal spine; in Rumack CM, Wilson SR, Charboneau JW, Levine D (eds): Diagnostic Ultrasound, ed 4. Philadelphia, Elsevier Mosby, 2011, pp 1245-1271.
17.
Nicolaides KH, Campbell S, Gabbe SG, Guidetti R: Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet 1986;12:2:72-74.
18.
Campbell J, Gilbert WM, Nicolaides KH, Campbell S: Ultrasound screening for spina bifida: cranial and cerebellar signs in a high-risk population. Obstet Gynecol 1987;70:247-250.
19.
Nyberg DA, Mack LA, Hirsch J, Mahony BS: Abnormalities of fetal cranial contour in sonographic detection of spina bifida: evaluation of the ‘lemon' sign. Radiology 1988;167:387-392.
20.
McLone DG, Knepper PA: The cause of Chiari II malformation: a unified theory. Pediatr Neurosci 1989;15:1-12.
21.
Cameron M, Moran P: Prenatal screening and diagnosis of neural tube defects. Prenat Diagn 2009;29:402-411.
22.
Van de Hof MC, Nicolaides KH, Campbell J, Campbell S: Evaluation of the lemon and banana in one hundred thirty fetuses with open spina bifida. Am J Obstet Gynecol 1990;162:322-327.
23.
D'Addario V, Rossi AC, Pinto V, Pintucci A, DiCagno L: Comparison of six sonographic signs in the prenatal diagnosis of spina bifida. J Perinat Med 2008;36:330-334.
24.
Biggio JR Jr, Wenstrom KD, Owen J: Fetal open spina bifida: a natural history of disease progression in utero. Prenat Diagn 2004;24:287-289.
25.
Filly RA: The ‘lemon' sign: a clinical perspective. Radiology 1988;167:573-575.
26.
Cardoza JD, Goldstein RB, Filly RA: Exclusion of fetal ventriculomegaly with a single measurement: the width of the lateral ventricular atrium. Radiology 1988;169:711-714.
27.
Babcook CJ, Goldstein RB, Barth RA, Damato NM: Prevalence of ventriculomegaly in association with myelomeningocele: correlation with gestational age and severity of posterior fossa deformity. Radiology 1994;190:703-707.
28.
Ghi T, Pilu G, Falco P, Segata M, Carletti A, Cocchi G, Santini D, Bonasoni P, Tani G, Rizzo N: Prenatal diagnosis of open and closed spina bifida. Ultrasound Obstet Gynecol 2006;28:899-903.
29.
Callen AL, Filly RA: Supratentorial abnormalities in the Chiari II malformation. I. The ventricular ‘point'. J Ultrasound Med 2008;27:33-38.
30.
Fujisawa H, Kitawaki J, Iwasa K, Honjo H: New ultrasonographic criteria for the prenatal diagnosis of Chiari type 2 malformations. Acta Obstet Gynecol Scand 2006;85:1426-1429.
31.
Goldstein RB, Podrasky AE, Filly RA, Callen PW: Effacement of the fetal cistern in association with myelomeningocele. Radiology 1989;172:409-413.
32.
D'Addario V, Pinto V, Del Bianco A, Di Naro E, Tartagni M, Miniello G, Serio G: The clivus-supraocciput angle: a useful measurement to evaluate the shape and size of the fetal posterior fossa and to diagnose Chiari II malformation. Ultrasound Obstet Gynecol 2001;18:146-149.
33.
Miller E, Widjaja E, Blaser S, Dennis M, Raybaud C: The old and the new: supratentorial MR findings in Chiari II malformation. Childs Nerv Syst 2008;24:563-575.
34.
Hino-Shishikura A, Niwa T, Aida N, Okabe T, Nagaoka T, Shibasaki J: Periventricular nodular heterotopia is related to severity of the hindbrain deformity in Chiari II malformation. Pediatr Radiol 2012;42:1212-1217.
35.
Gilbert JN, Jones KL, Rorke LB, Chernoff GF, James HE: Central nervous system anomalies associated with meningomyelocele hydrocephalus, and the Arnold-Chiari malformation; reappraisal of theories regarding the pathogeneses' of posterior neural tube closure defects. Neurosurgery 1986;18:559-564.
36.
Malinger G, Kidron D, Schreiber L, Ben-Sira L, Hoffman C, Lev D, Lerman-Sagie T: Prenatal diagnosis of malformations of cortical development by dedicated neurosonography. Ultrasound Obstet Gynecol 2007;29:178-191.
37.
Benacerraf BR, Shipp TD, Bromley B, Levine D: What does magnetic resonance imaging add to the prenatal sonographic diagnosis of ventriculomegaly? J Ultrasound Med 2007;26:1513-1522.
38.
McGahan JP, Haesslein HC, Meyers M, Ford KB: Sonographic recognition of in utero intraventricular hemorrhage. AJR Am J Roentgenol 1984;142:171-173.
39.
Groothuis AM, Kleine MJ, Oei SG: Intraventricular haemorrhage in utero: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol 2000;89:207-211.
40.
Tsitouras V, Sgouros S: Syringomyelia and tethered cord in children. Childs Nerv Syst 2013;29:1625-1634.
41.
Cho FN, Kan YY, Yang TL, Huang HP, Hsu PH, Mai, MH: Prenatal diagnosis of sharp-angled lumbosacral kyphosis with MMC and spina bifida in a fetus. J Ultrasound Med 2004;22:1115-1119.
43.
Shorey WD: Diastematomyelia associated with dorsal kyphosis producing paraplegia. J Neurosurg 1955;12:300-305.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.